Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 4,181 shares at $2.82 ($12K) on 2021-11-19, disclosed to the SEC on 2021-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.88 | 681 | $2K | 16.6% |
| 2 | $2.82 | 3,500 | $10K | 83.4% |
| Total | $2.83 avg | 4,181 | $12K | 100% |
| Filing → |
| TCON | BUY | 2023-01-19 | $11K | — | Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |